
Investment trust
RTW Biotech Opportunities Ord
- ISIN
- GG00BKTRRM22
- Category
- Sector Equity Biotechnology
How good is this fund, really?
See the rating in the appAbout RTW Biotech Opportunities Ord
Biotechnology and medical technology are the sole sectors for this Guernsey closed-ended company, externally managed by RTW Investments, LP. It aims for positive absolute performance and long-term capital growth by backing firms that develop new drugs or medical devices, holding a diversified portfolio. The key information document puts exposure to the United States at 73% as of 31 March 2026. Shares were admitted to the London Stock Exchange in October 2019, and the company took its present name in June 2023, having been called RTW Venture Fund Limited. It has no fixed life. The risk indicator is 5 of 7, the recommended holding period is 5 years, and no capital protection is offered.
Watch this fund for free Add RTW Biotech Opportunities Ord to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.
Watch the fund for freeWhere to buy RTW Biotech Opportunities Ord — platforms and fees
Sold on 3 platforms we follow.
-
AJ Bell Annual fee: See the platformGo to AJ Bell ↗
-
Hargreaves Lansdown Annual fee: See the platformGo to Hargreaves Lansdown ↗
-
interactive investor Annual fee: See the platformGo to interactive investor ↗
RTW Biotech Opportunities Ord — its category
Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.
Biotechnology funds →Other funds
- Global X Genomics & Biotech ETF USD Acc
- International Biotechnology Ord
- Invesco NASDAQ Biotech ETF
- iShares Nasdaq US Biotech ETF USD Acc
- iShares Nasdaq US Biotech ETF USD Dist
- Janus Henderson Hrzn Biotec H2 USD
- JPM Thmtcs Gentc Thrps C dist GBP
- L&G Pharma Breakthrough ETF
- LS ARK Genomic Revolution Trkr ETP Scs
- Pictet-Biotech I dy GBP
- Polar Capital Biotech I Inc
- WisdomTree BioRevolution ETF - USD Acc